LPAR1 and chronic intestinal pseudoobstruction: Indeed, LPA, the ligand for LPAR1, which may also be a product of ether lipids metabolism (significantly reduced in our CIPO patients cohorts), was reported to reduce colonic contractility and thus modulate colonic motor complexes, likely through its proinflammatory effect on enteric glia.39